Dec 5 (Reuters) - Nymox Pharmaceutical Corp:
* NYMOX ANNOUNCES NEW MARKETING SUBMISSION FOR NYMOZARFEX™ FOR BPH
* NYMOX PHARMACEUTICAL CORP - ANNOUNCE A NEW FORMAL SUBMISSION HAS BEEN MADE IN EUROPE FOR FEXAPOTIDE TRIFLUTATE FOR TREATMENT BPH
* NYMOX PHARMACEUTICAL CORP - MARKETING AUTHORIZATION APPLICATION (MAA) WAS SUBMITTED TO DANISH AUTHORITIES Source text for Eikon: Further company coverage: